Msg 111668 of 115519 at 12/23/2019 10:27:40 AM by

pharmionphil

edit | delete
The following message was updated on 12/23/2019 11:15:35 AM.


OTIDRA private placement—Aint over till its over always true
Has been brutal as hedge funds stymied the Baker Bros proposed merger that wrecked the stock.

However this capital will allow the bridge to Phase3 data for tiltosimod.

Risk tolerant folks get the stock today at about $0.22c per share split

Phase3 trial funded for pennies is the risk reward today.

$1.68 your risk

Do your DD